170 related articles for article (PubMed ID: 7631511)
1. Adjuvanticity of ISCOMs incorporating a T cell-reactive lipoprotein of the facultative intracellular pathogen Francisella tularensis.
Golovliov I; Ericsson M; Akerblom L; Sandström G; Tärnvik A; Sjöstedt A
Vaccine; 1995 Feb; 13(3):261-7. PubMed ID: 7631511
[TBL] [Abstract][Full Text] [Related]
2. Humoral and cell-mediated immunity in mice to a 17-kilodalton lipoprotein of Francisella tularensis expressed by Salmonella typhimurium.
Sjöstedt A; Sandström G; Tärnvik A
Infect Immun; 1992 Jul; 60(7):2855-62. PubMed ID: 1612751
[TBL] [Abstract][Full Text] [Related]
3. Protective immunity against tularemia provided by an adenovirus-vectored vaccine expressing Tul4 of Francisella tularensis.
Kaur R; Chen S; Arévalo MT; Xu Q; Chen Y; Zeng M
Clin Vaccine Immunol; 2012 Mar; 19(3):359-64. PubMed ID: 22278325
[TBL] [Abstract][Full Text] [Related]
4. A Synthetic Tul4 and FopA Peptide Cocktail of Francisella tularensis Induces Humoral and Cell-Mediated Immune Responses in Mice.
Oh H; Kim CY; Kim CH; Hur GH; Park JH
J Microbiol Biotechnol; 2016 Sep; 26(9):1613-9. PubMed ID: 27238938
[TBL] [Abstract][Full Text] [Related]
5. Immunodominant Francisella tularensis antigens identified using proteome microarray.
Eyles JE; Unal B; Hartley MG; Newstead SL; Flick-Smith H; Prior JL; Oyston PC; Randall A; Mu Y; Hirst S; Molina DM; Davies DH; Milne T; Griffin KF; Baldi P; Titball RW; Felgner PL
Proteomics; 2007 Jun; 7(13):2172-83. PubMed ID: 17533643
[TBL] [Abstract][Full Text] [Related]
6. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
KuoLee R; Harris G; Conlan JW; Chen W
Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
[TBL] [Abstract][Full Text] [Related]
7. Identification of a dominant CD4 T cell epitope in the membrane lipoprotein Tul4 from Francisella tularensis LVS.
Valentino MD; Hensley LL; Skrombolas D; McPherson PL; Woolard MD; Kawula TH; Frelinger JA; Frelinger JG
Mol Immunol; 2009 May; 46(8-9):1830-8. PubMed ID: 19233475
[TBL] [Abstract][Full Text] [Related]
8. Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia.
Hickey AJ; Hazlett KR; Kirimanjeswara GS; Metzger DW
Vaccine; 2011 Sep; 29(40):6941-7. PubMed ID: 21803089
[TBL] [Abstract][Full Text] [Related]
9. Intranasal administration of a two-dose adjuvanted multi-antigen TMV-subunit conjugate vaccine fully protects mice against Francisella tularensis LVS challenge.
McCormick AA; Shakeel A; Yi C; Kaur H; Mansour AM; Bakshi CS
PLoS One; 2018; 13(4):e0194614. PubMed ID: 29684046
[TBL] [Abstract][Full Text] [Related]
10. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
Jia Q; Bowen R; Lee BY; Dillon BJ; Masleša-Galić S; Horwitz MA
Vaccine; 2016 Sep; 34(41):4969-4978. PubMed ID: 27577555
[TBL] [Abstract][Full Text] [Related]
11. Specific antibodies protect gamma-irradiated mice against Francisella tularensis infection.
Kubelkova K; Krocova Z; Balonova L; Pejchal J; Stulik J; Macela A
Microb Pathog; 2012; 53(5-6):259-68. PubMed ID: 22841607
[TBL] [Abstract][Full Text] [Related]
12. Protection afforded against aerosol challenge by systemic immunisation with inactivated Francisella tularensis live vaccine strain (LVS).
Eyles JE; Hartley MG; Laws TR; Oyston PC; Griffin KF; Titball RW
Microb Pathog; 2008 Feb; 44(2):164-8. PubMed ID: 17904793
[TBL] [Abstract][Full Text] [Related]
13. Orchestration of the protective immune response to intracellular bacteria: Francisella tularensis as a model organism.
Tärnvik A; Ericsson M; Golovliov I; Sandström G; Sjöstedt A
FEMS Immunol Med Microbiol; 1996 Mar; 13(3):221-5. PubMed ID: 8861033
[TBL] [Abstract][Full Text] [Related]
14. Humanized Mice for the Evaluation of
Oh H; Kim CY; Kim CH; Hur GH; Lee JM; Chang SN; Park JH
J Microbiol Biotechnol; 2018 Jan; 28(1):157-164. PubMed ID: 29132197
[No Abstract] [Full Text] [Related]
15. Native outer membrane proteins protect mice against pulmonary challenge with virulent type A Francisella tularensis.
Huntley JF; Conley PG; Rasko DA; Hagman KE; Apicella MA; Norgard MV
Infect Immun; 2008 Aug; 76(8):3664-71. PubMed ID: 18505805
[TBL] [Abstract][Full Text] [Related]
16. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.
Wayne Conlan J; Shen H; Kuolee R; Zhao X; Chen W
Vaccine; 2005 Mar; 23(19):2477-85. PubMed ID: 15752834
[TBL] [Abstract][Full Text] [Related]
17. A mucosal subunit vaccine protects against lethal respiratory infection with Francisella tularensis LVS.
Ashtekar AR; Katz J; Xu Q; Michalek SM
PLoS One; 2012; 7(11):e50460. PubMed ID: 23209745
[TBL] [Abstract][Full Text] [Related]
18. Nature of protective immunity to Francisella tularensis.
Tärnvik A
Rev Infect Dis; 1989; 11(3):440-51. PubMed ID: 2665002
[TBL] [Abstract][Full Text] [Related]
19. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.
Baron SD; Singh R; Metzger DW
Infect Immun; 2007 May; 75(5):2152-62. PubMed ID: 17296747
[TBL] [Abstract][Full Text] [Related]
20. Immunological markers that correlate with protection immunity against tularemia infection.
Firstova VV; Mokrievich AN; Pavlov VM; Gorbatov AA; Kombarova TI; Biketov SF; Dyatlov IA
Adv Exp Med Biol; 2014; 808():15-23. PubMed ID: 24595607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
